Development of lung and muscle protein factories to deliver therapeutic monoclonal antibodies

Development of lung and muscle protein factories to deliver therapeutic monoclonal antibodies

Recombinant therapeutic proteins, of which monoclonal antibodies (mAbs) represent the largest market, are used to treat diseases including cancer, blood and immune disorders. The cost and complexity of large-scale production and purification of mAbs translates to high cost of therapy. We hypothesise...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Antepowicz, A, Tan, A, Pringle, A, Hyde, S, Gill, D
Fformat:	Conference item
Cyhoeddwyd:	Mary Ann Liebert Inc 2016

Eitemau Tebyg

Development of lung and muscle factories to deliver therapeutic monoclonal antibodies
gan: Antepowicz, A
Cyhoeddwyd: (2018)

431. Lung antibody factory for passive immunisation against influenza
gan: Tan, T, et al.
Cyhoeddwyd: (2016)

Lentiviral-mediated expression of monoclonal antibodies in the lung to protect against influenza
gan: Du, Y, et al.
Cyhoeddwyd: (2020)

Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
gan: Antepowicz, A, et al.
Cyhoeddwyd: (2018)

The lung as a factory to produce secreted intrapulmonary and circulatory proteins
gan: Paul-Smith, M, et al.
Cyhoeddwyd: (2017)

Development of monoclonal antibody therapeutics for alzheimer's disease
gan: Masatoshi Takeda
Cyhoeddwyd: (2022-01-01)

The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins
gan: Paul-Smith, M, et al.
Cyhoeddwyd: (2018)

Monoclonal Antibodies as Neurological Therapeutics
gan: Panagiotis Gklinos, et al.
Cyhoeddwyd: (2021-01-01)

Therapeutic monoclonal antibody for Sporotrichosis
gan: Sandro eAlmeida
Cyhoeddwyd: (2012-11-01)

The development of gene therapy for diseases of the lung.
gan: Gill, DR, et al.
Cyhoeddwyd: (2004)

Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections
gan: Leonardo F. Ormundo, et al.
Cyhoeddwyd: (2023-10-01)

Advances and challenges in therapeutic monoclonal antibodies drug development
gan: Mariana Lopes dos Santos, et al.
Cyhoeddwyd: (2018-11-01)

Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development
gan: Rosalynn Molden, et al.
Cyhoeddwyd: (2021-01-01)

Monoclonal antibodies for the therapeutic induction of tolerance.
gan: Waldmann, H, et al.
Cyhoeddwyd: (1993)

Therapeutic potential of monovalent monoclonal antibodies.
gan: Cobbold, S, et al.
Cyhoeddwyd: (1984)

The pharmacology and therapeutic applications of monoclonal antibodies
gan: María Sofía Castelli, et al.
Cyhoeddwyd: (2019-12-01)

Development and validation of an analytical procedure for the determination of residual protein A in active substances of therapeutic monoclonal antibodies
gan: E. V. Nozdrina, et al.
Cyhoeddwyd: (2024-03-01)

Therapeutic Monoclonal Antibodies against Cancer: Present and Future
gan: Marisa Delgado, et al.
Cyhoeddwyd: (2023-12-01)

Development of an anti-Pseudomonas aeruginosa therapeutic monoclonal antibody WVDC-5244
gan: Alexander M. Horspool, et al.
Cyhoeddwyd: (2023-04-01)

Development and Characterization of Monoclonal Antibodies for the Detection of Fish Protein
gan: Yi-Tien Chen, et al.
Cyhoeddwyd: (2021-10-01)

Corrigendum: Therapeutic potential of monovalent monoclonal antibodies
gan: Cobbold, S, et al.
Cyhoeddwyd: (1984)

Therapeutic Uses of Monoclonal Antibodies for COVID-19
gan: Tarun Kumar Suvvari
Cyhoeddwyd: (2020-01-01)

Intramuscular rAAV2/8 mediated expression of etanercept in mice with collagen-induced arthritis
gan: Habib, O, et al.
Cyhoeddwyd: (2019)

Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery
gan: Pringle, I, et al.
Cyhoeddwyd: (2018)

DEVELOPMENT AND PROPERTIES OF NEUTRALIZING MONOCLONAL ANTIBODIES FOR FUSION PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS
gan: A. A. Kushch, et al.
Cyhoeddwyd: (2019-04-01)

Therapeutic potential of monoclonal antibodies to the leucocyte common antigen.
gan: Bindon, C, et al.
Cyhoeddwyd: (1985)

Identification and characterisation of candidate monoclonal antibody Ebolavirus therapeutics
gan: Donnellan, FR
Cyhoeddwyd: (2021)

Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease
gan: Alvaro Barrera-Ocampo
Cyhoeddwyd: (2024-07-01)

Therapeutic monoclonal antibodies with a focus on hereditary angioedema
gan: Bruce L. Zuraw, et al.
Cyhoeddwyd: (2023-01-01)

Monoclonal Antibodies Targeting Ion Channels and Their Therapeutic Potential
gan: Aurélien Haustrate, et al.
Cyhoeddwyd: (2019-06-01)

The history and potential future of monoclonal antibody therapeutics development and manufacturing in four eras
gan: Brian Kelley
Cyhoeddwyd: (2024-12-01)

Developing Monoclonal Antibodies for Immunohistochemistry
gan: Jacqueline Cordell
Cyhoeddwyd: (2022-01-01)

Binding of omeprazole to protein targets identified by monoclonal antibodies
gan: Naw May Pearl Cartee, et al.
Cyhoeddwyd: (2020-01-01)

Impact of Urea on Monoclonal Antibodies: Multiple Destabilization and Aggregation Effects for Therapeutic Immunoglobulin G Proteins
gan: Ji Young Yang, et al.
Cyhoeddwyd: (2024-01-01)

Monoclonal antibody techniques. 50 years of development
gan: Yulia S. Massino, et al.
Cyhoeddwyd: (2024-07-01)

Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins
gan: Liming Liu
Cyhoeddwyd: (2017-04-01)

Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environments
gan: C Ian Mockridge, et al.
Cyhoeddwyd: (2022-01-01)

Therapy with monoclonal antibodies. An in vivo model for the assessment of therapeutic potential.
gan: Isaacs, J, et al.
Cyhoeddwyd: (1992)

Monoclonal antibodies: a review of therapeutic applications and future prospects
gan: Mahmuda, Aliyu, et al.
Cyhoeddwyd: (2017)

Monoclonal Antibodies in Modern Medicine: Their Therapeutic Potential and Future Directions
gan: Samuel Ebele Udeabor
Cyhoeddwyd: (2024-12-01)